---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-076761"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:32:24.345536+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences adjusts warrant exercise price to $2.39 per share

## Summary
- Class C warrants now exercisable for 1/30th of a common share at $2.39 per share.
- Class D warrants now exercisable for one common share at $2.39 per share.
- Cede & Co. cannot process exercises at adjusted price until DTC system updates.
- Warrant holders may exercise by sending Notice to Continental Stock Transfer with DWAC instructions.

## SEC filing metadata
- accession: 0000950170-24-076761
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017024076761/0000950170-24-076761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024076761/revb-20240624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-076761
- JSON: https://secwatch.observer/filing/0000950170-24-076761.json
- Plain text: https://secwatch.observer/filing/0000950170-24-076761.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.